Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Erbitux 100 mg Infusion:
Erbitux 100 mg Infusion is used in the treatment of head and neck cancer and colorectal cancer. It helps mark the cancer cells for destruction by the body's immune system.
Erbitux 100 mg Infusion is administered as an infusion under the supervision of a specialist. Your doctor will determine the appropriate dosage and frequency of administration for you. This will depend on the condition you are being treated for and may change over time. You should take it exactly as your doctor has advised. Misinterpreting it or taking too much can cause serious side effects. Do not stop taking it unless your doctor tells you to.
Uses of Erbitux 100 mg Infusion:
Head and neck cancer
Colorectal cancer
Benefits of Erbitux 100 mg Infusion:
In Head and neck cancer:
Head and neck cancer includes cancer of the mouth, nose, sinuses, or throat. Erbitux 100 mg Infusion kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and highly toxic medication, so you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while undergoing this treatment and drink plenty of water to stay hydrated.
In Colorectal cancer:
Colorectal cancer, also known as bowel cancer, is the development of cancer from two parts of the intestine, namely, the colon or rectum. In this type of cancer, individuals may experience symptoms such as blood in the stool, changes in bowel habits, weight loss, and fatigue. Erbitux 100 mg Infusion treats and also reduces the risk of developing further malignant growths (polyps) and colorectal cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent medication but causes some troublesome side effects. Consult your physician if you have any concerns.
Mechanism of Action of Erbitux 100 mg Infusion:
Erbitux 100 mg Infusion is a monoclonal antibody that specifically binds to receptors on cancer cells. As a result, it signals the cancer cells for destruction by the body's immune system.